Fuse Oncology, a provider of specialized healthcare software solutions for oncology, today announced a strategic partnership with Elekta, a global leader in precision radiation therapy. This collaboration introduces Fuse Oncology’s S!GNAL platform to Elekta’s U.S. customer network, offering tools to enhance revenue, streamline compliance, and boost operational efficiency across radiation oncology practices.
“In an environment where reimbursement rates continue to decline while costs of care escalate, we’re excited to partner with Elekta to bring meaningful financial and operational benefits to radiation oncology clinics nationwide,” said Ric Downs, Vice President of Sales at Fuse Oncology.
The S!GNAL platform addresses common challenges in radiation oncology billing and coding by identifying and tracking key clinical and business data at the charge capture level. Its automated revenue cycle verification streamlines documentation access, provides real-time coding guidance, and helps ensure billing compliance. In addition, S!GNAL’s integrated business intelligence tools enable practices to optimize workflows, improve coding accuracy, recover missed charges, and identify new revenue opportunities.
“With S!GNAL, our customers will be able to virtually eliminate charge capture errors, recover overlooked charges, and run more efficient operations,” said Chad Poulliotte, Vice President and Head of Software Solutions, Region Americas, at Elekta. “The resulting improvements in revenue cycle management will deliver significant financial impact for clinics across the country.”
Through this partnership, Fuse Oncology’s innovative platform brings U.S. radiation oncology providers powerful new capabilities to strengthen financial performance and operational efficiency.